DK0938496T3 - Heptapeptidoxytocinanaloger - Google Patents

Heptapeptidoxytocinanaloger

Info

Publication number: DK0938496T3
Authority: DK; Denmark
Prior art keywords: oxytocin analogs; heptapeptide; heptapeptide oxytocin; analogs; oxytocin
Prior art date: 1996-11-26

Application number

DK97946210T

Other languages

English (en)

Inventor

Per Melin

Anders Nilsson

Jerzy Trojnar

Carl-Johan Aurell

Pierre Riviere

Robert Haigh

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-26

Filing date

1997-11-21

Publication date

2003-10-06

1997-11-21 Application filed by Ferring Bv filed Critical Ferring Bv

2003-10-06 Application granted granted Critical

2003-10-06 Publication of DK0938496T3 publication Critical patent/DK0938496T3/da

Links

XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Neurology (AREA)
Biochemistry (AREA)
Pregnancy & Childbirth (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK97946210T 1996-11-26 1997-11-21 Heptapeptidoxytocinanaloger DK0938496T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9604341A SE9604341D0 (sv)	1996-11-26	1996-11-26	Hepta-peptide oxytocin analogue
PCT/SE1997/001968 WO1998023636A1 (en)	1996-11-26	1997-11-21	Heptapeptide oxytocin analogues

Publications (1)

Publication Number	Publication Date
DK0938496T3 true DK0938496T3 (da)	2003-10-06

Family

ID=20404757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97946210T DK0938496T3 (da)	1996-11-26	1997-11-21	Heptapeptidoxytocinanaloger

Country Status (34)

Country	Link
US (1)	US6143722A (da)
EP (1)	EP0938496B1 (da)
JP (1)	JP3405460B2 (da)
KR (1)	KR100463132B1 (da)
CN (1)	CN1129606C (da)
AR (1)	AR008531A1 (da)
AT (1)	ATE242264T1 (da)
AU (1)	AU713424B2 (da)
BR (1)	BR9713366B1 (da)
CA (1)	CA2272990C (da)
CZ (1)	CZ299532B6 (da)
DE (1)	DE69722651T2 (da)
DK (1)	DK0938496T3 (da)
EE (1)	EE03832B1 (da)
ES (1)	ES2203823T3 (da)
HR (1)	HRP970630B1 (da)
HU (1)	HU228568B1 (da)
IL (1)	IL129519A (da)
LT (1)	LT4650B (da)
LV (1)	LV12350B (da)
MY (1)	MY125555A (da)
NO (1)	NO321380B1 (da)
NZ (1)	NZ336445A (da)
PL (1)	PL189292B1 (da)
PT (1)	PT938496E (da)
RO (1)	RO120772B1 (da)
RU (1)	RU2180668C2 (da)
SE (1)	SE9604341D0 (da)
SI (1)	SI20026B (da)
SK (1)	SK283800B6 (da)
TR (1)	TR199901028T2 (da)
UA (1)	UA54459C2 (da)
WO (1)	WO1998023636A1 (da)
ZA (1)	ZA9710518B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2181297C2 (ru)	2000-06-20	2002-04-20	Эпштейн Олег Ильич	Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) *	2000-11-21	2002-11-05	Arthur Vanmoor	Method of treating menstrual pain by enhancing the effectiveness of the human immune system
DK1480998T3 (da) *	2002-02-27	2007-03-26	Ferring Bv	Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
WO2003093816A2 (en) *	2002-05-02	2003-11-13	Bayer Healtchare Ag	Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
UA76639C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
ATE301990T1 (de) *	2003-07-25	2005-09-15	Ferring Bv	Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
PT1530967E (pt) *	2003-11-13	2006-09-29	Ferring Bv	Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
EP1555029A1 (en)	2004-01-19	2005-07-20	Ferring B.V.	Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US20060171909A1 (en) *	2005-02-03	2006-08-03	The Procter & Gamble Company	Cosmetic compositions comprising colorants with low free dye
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
WO2009021007A1 (en)	2007-08-06	2009-02-12	Serenity Pharmaceuticals Corporation	Methods and devices for desmopressin drug delivery
RU2496788C2 (ru) *	2008-03-31	2013-10-27	Ферринг Б.В.	Аналоги окситоцина
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
NO3085381T3 (da)	2008-05-21	2018-09-15
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
TWI463990B (zh) *	2009-09-21	2014-12-11	Ferring Bv	催產素受體促進劑
CA2804966A1 (en)	2010-07-15	2012-01-19	Oleg Iliich Epshtein	A method of increasing the effect of an activated-potentiated form of an antibody
JO3400B1 (ar) *	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
CN103415530A (zh)	2011-03-09	2013-11-27	Jitsubo株式会社	新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
CN102875650B (zh) *	2012-09-26	2014-06-11	深圳翰宇药业股份有限公司	巴卢西班的制备方法
US9365615B2 (en)	2013-09-09	2016-06-14	Jitsubo Co., Ltd.	Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
PL3037101T3 (pl)	2014-12-22	2019-06-28	Ferring B.V.	Terapia antagonistą receptora oksytocyny w fazie lutealnej w celu implantacji i uzyskania ciąży u kobiet poddawanych technikom wspomaganego rozrodu
US9750785B2 (en)	2015-01-30	2017-09-05	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en)	2015-01-30	2016-06-28	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en)	2015-01-30	2017-06-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en)	2015-01-30	2017-08-29	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en)	2015-01-30	2018-03-27	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en)	2015-01-30	2018-04-10	Par Pharmaceutical, Inc.	Vasopressin formulations for use in treatment of hypotension
WO2017060339A1 (en)	2015-10-06	2017-04-13	Ferring B.V.	New methods for making barusiban and its intermediates
SG10202009723PA (en)	2016-01-04	2020-11-27	ObsEva SA	Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
WO2018015497A2 (en)	2016-07-21	2018-01-25	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20220323410A1 (en)	2019-09-03	2022-10-13	ObsEva S.A.	Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CN115380122A (zh)	2020-02-10	2022-11-22	奥布赛瓦股份公司	用于催产素受体拮抗剂疗法的生物标志物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL155712B1 (en) *	1987-12-21	1991-12-31	Sandoz Ag	Method of obtaining novel crystalline form of cyclosporin
US5373089A (en) *	1988-09-02	1994-12-13	Northwestern University	Oxytocin antagonist
CA2036973A1 (en) *	1990-02-27	1991-08-28	Mark G. Bock	Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) *	1990-07-09	1990-07-09	Ferring Ab	Derivat av baklobshormoner
DE4022247A1 (de) *	1990-07-12	1992-01-16	Hoechst Ag	Verfahren zur extraktiven abtrennung von 2-alkylthio-5-phenylpyrimidinen aus ihren reaktionsgemischen
SE501678C2 (sv) *	1993-07-13	1995-04-10	Ferring Bv	Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv)	1994-01-27	2004-05-18	Per-Ingvar Nilsson	Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv)	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
SE503085C2 (sv)	1995-01-25	1996-03-25	Valeo Engine Cooling Ab	Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

1996
- 1996-11-26 SE SE9604341A patent/SE9604341D0/xx unknown
1997
- 1997-11-21 SK SK704-99A patent/SK283800B6/sk not_active IP Right Cessation
- 1997-11-21 HU HU0000577A patent/HU228568B1/hu unknown
- 1997-11-21 IL IL12951997A patent/IL129519A/en not_active IP Right Cessation
- 1997-11-21 RO RO99-00593A patent/RO120772B1/ro unknown
- 1997-11-21 EE EEP199900210A patent/EE03832B1/xx unknown
- 1997-11-21 CN CN97180014A patent/CN1129606C/zh not_active Expired - Fee Related
- 1997-11-21 RU RU99113364/04A patent/RU2180668C2/ru active
- 1997-11-21 SI SI9720076A patent/SI20026B/sl unknown
- 1997-11-21 WO PCT/SE1997/001968 patent/WO1998023636A1/en not_active Ceased
- 1997-11-21 US US09/308,912 patent/US6143722A/en not_active Expired - Lifetime
- 1997-11-21 ES ES97946210T patent/ES2203823T3/es not_active Expired - Lifetime
- 1997-11-21 BR BRPI9713366-3A patent/BR9713366B1/pt not_active IP Right Cessation
- 1997-11-21 PL PL97333876A patent/PL189292B1/pl unknown
- 1997-11-21 TR TR1999/01028T patent/TR199901028T2/xx unknown
- 1997-11-21 DK DK97946210T patent/DK0938496T3/da active
- 1997-11-21 HR HR970630A patent/HRP970630B1/xx not_active IP Right Cessation
- 1997-11-21 KR KR10-1999-7004449A patent/KR100463132B1/ko not_active Expired - Lifetime
- 1997-11-21 AU AU51429/98A patent/AU713424B2/en not_active Expired
- 1997-11-21 CA CA002272990A patent/CA2272990C/en not_active Expired - Lifetime
- 1997-11-21 JP JP52460298A patent/JP3405460B2/ja not_active Expired - Lifetime
- 1997-11-21 ZA ZA9710518A patent/ZA9710518B/xx unknown
- 1997-11-21 DE DE69722651T patent/DE69722651T2/de not_active Expired - Lifetime
- 1997-11-21 UA UA99042410A patent/UA54459C2/uk unknown
- 1997-11-21 AT AT97946210T patent/ATE242264T1/de active
- 1997-11-21 PT PT97946210T patent/PT938496E/pt unknown
- 1997-11-21 EP EP97946210A patent/EP0938496B1/en not_active Expired - Lifetime
- 1997-11-21 NZ NZ336445A patent/NZ336445A/en not_active IP Right Cessation
- 1997-11-21 CZ CZ0183299A patent/CZ299532B6/cs not_active IP Right Cessation
- 1997-11-25 MY MYPI97005691A patent/MY125555A/en unknown
- 1997-11-26 AR ARP970105543A patent/AR008531A1/es active IP Right Grant
1999
- 1999-04-30 LV LVP-99-77A patent/LV12350B/en unknown
- 1999-05-11 LT LT99-052A patent/LT4650B/lt not_active IP Right Cessation
- 1999-05-26 NO NO19992532A patent/NO321380B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
LV12350A (lv)	1999-09-20
WO1998023636A1 (en)	1998-06-04
EE9900210A (et)	1999-12-15
AU713424B2 (en)	1999-12-02
BR9713366B1 (pt)	2010-05-18
CZ299532B6 (cs)	2008-08-27
ATE242264T1 (de)	2003-06-15
JP3405460B2 (ja)	2003-05-12
NO992532L (no)	1999-05-26
LT4650B (lt)	2000-04-25
ZA9710518B (en)	1998-06-10
CN1238781A (zh)	1999-12-15
LT99052A (en)	2000-01-25
HRP970630B1 (en)	2002-04-30
HUP0000577A3 (en)	2001-02-28
JP2000507617A (ja)	2000-06-20
MY125555A (en)	2006-08-30
PT938496E (pt)	2003-10-31
PL189292B1 (pl)	2005-07-29
HU228568B1 (en)	2013-04-29
NO321380B1 (no)	2006-05-02
CZ183299A3 (cs)	2000-05-17
AU5142998A (en)	1998-06-22
DE69722651D1 (en)	2003-07-10
HUP0000577A2 (hu)	2000-11-28
AR008531A1 (es)	2000-01-19
KR100463132B1 (ko)	2004-12-23
SE9604341D0 (sv)	1996-11-26
TR199901028T2 (xx)	1999-07-21
NZ336445A (en)	2000-06-23
SI20026A (sl)	2000-02-29
SI20026B (sl)	2000-06-30
DE69722651T2 (de)	2004-04-08
ES2203823T3 (es)	2004-04-16
CA2272990A1 (en)	1998-06-04
CN1129606C (zh)	2003-12-03
SK283800B6 (sk)	2004-02-03
BR9713366A (pt)	2000-01-25
US6143722A (en)	2000-11-07
LV12350B (en)	1999-11-20
IL129519A0 (en)	2000-02-29
NO992532D0 (no)	1999-05-26
HK1022481A1 (en)	2000-08-11
RO120772B1 (ro)	2006-07-28
UA54459C2 (uk)	2003-03-17
KR20000069045A (ko)	2000-11-25
EP0938496A1 (en)	1999-09-01
EP0938496B1 (en)	2003-06-04
IL129519A (en)	2004-09-27
CA2272990C (en)	2002-11-19
RU2180668C2 (ru)	2002-03-20
HRP970630A2 (en)	1998-10-31
SK70499A3 (en)	2000-10-09
EE03832B1 (et)	2002-08-15

Publication	Publication Date	Title
NO992532L (no)	1999-05-26	Heptapeptid oksytocinanaloger
FI965225A7 (fi)	1997-02-26	Uusia peptidejä
NO983069D0 (no)	1998-07-02	Inhalasjonsanordning
DK1042359T3 (da)	2005-11-28	k-Opioidreceptorpeptider
DE59707564D1 (de)	2002-07-25	Fungizide mischung
FI961350L (fi)	1996-03-25	Hapteenimerkityt peptidit
FI102731B1 (fi)	1999-02-15	Näyteputki
FR2747926B1 (fr)	2001-05-11	Inhalateurs ameliores
DE59806407D1 (de)	2003-01-09	Drucktaster
NO985680L (no)	1999-02-04	Peptidderivater
EP0985372A4 (en)	2004-06-02	VACUUM CLEANER
EP0996458A4 (en)	2001-05-02	SANDRAMYCIN ANALOG
NO983849L (no)	1998-10-21	Peptidderivater
FI970168A7 (fi)	1997-01-15	Peptidejä
FI963194A7 (fi)	1996-09-23	Syklinen tulehduksenvastainen heptapeptidi
DE69819097D1 (de)	2003-11-27	Drucktaster
DE59801799D1 (de)	2001-11-22	Reinigungsgerät
DE59803807D1 (de)	2002-05-23	Reinigungsgerät
DE59706870D1 (de)	2002-05-08	Fungizide mischung
DK1137667T3 (da)	2005-02-14	GLP-1-analoger
DE69715327D1 (de)	2002-10-17	Reinigungsgerät
FI950211A7 (fi)	1995-07-20	Huokosia muodostavia peptidejä Geolycosa riograndesta
DE19882184T1 (de)	2000-02-10	Cyclosporin enthaltende Präparation
DE59811930D1 (de)	2004-10-21	Drucktaster
KR970056542U (ko)	1997-11-10	넥타이